Cited by 389Metabolism, Diabetes, and CancerUbiquitin and proteasome pathwaysPI3K/AKT/mTOR signaling in cancer

Degradation of AMPK by a Cancer-Specific Ubiquitin Ligase

Open access
Pineda, Carlos T., Ramanathan, Saumya, Fon Tacer, Klementina, Weon, Jenny L., Potts, Malia B., Ou, Yi-Hung, White, Michael A., Potts, Patrick Ryan·2015·Cell

Abstract

AMP-activated protein kinase (AMPK) is a master sensor and regulator of cellular energy status. Upon metabolic stress, AMPK suppresses anabolic and promotes catabolic processes to regain energy homeostasis. Cancer cells can occasionally suppress the growth-restrictive AMPK pathway by mutation of an upstream regulatory kinase. Here, we describe a widespread mechanism to suppress AMPK through its ubiquitination and degradation by the cancer-specific MAGE-A3/6-TRIM28 ubiquitin ligase. MAGE-A3 and MAGE-A6 are highly similar proteins normally expressed only in the male germline but frequently re-activated in human cancers. MAGE-A3/6 are necessary for cancer cell viability and are sufficient to drive tumorigenic properties of non-cancerous cells. Screening for targets of MAGE-A3/6-TRIM28 revealed that it ubiquitinates and degrades AMPKα1. This leads to inhibition of autophagy, activation of mTOR signaling, and hypersensitization to AMPK agonists, such as metformin. These findings elucidate a germline mechanism commonly hijacked in cancer to suppress AMPK.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cell.2015.01.034

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The MAGE family of ubiquitin E3 ligases, often called MAGE-RING ligases (MRLs), comprise proteins that serve as substrate-recruitment modules for other RING E3 ligases, adding to and/or altering the substrate specificity of their co-E3 ligases.

    “An example of such a family of ligases are the MAGE (melanoma antigen genes) family of ubiquitin E3 ligases, often referred to as the MAGE-RING ligases (MRLs), which comprise proteins that serve as substrate-recruitment modules for other RING E3 ligases156,157, adding to and/or altering the substrate specificity of their co-E3 ligases (reviewed elsewhere155,158).”

    From PROTAC targeted protein degraders: the past is prologue (2022) · cites this paper as [157]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 70 · Cited by 389

Authors
Pineda, C. T., Ramanathan, S., Fon Tacer, K., Weon, J. L., Potts, M. B., Ou, Y.-H., White, M. A., & Potts, P. R.
Affiliations
The University of Texas Southwestern Medical Center (US)
Corresponding author
Potts, Patrick Ryan
Venue
Cell
Publisher
Elsevier BV
Published
2015-02
Volume
160
Issue
4
Pages
715-728
ISSN
0092-8674 (ISSN-L)
OpenAlex
W1967199837
Cited by
389
References
70
Citations by year
2026: 16 · 2025: 29 · 2024: 61 · 2023: 37 · 2022: 36 · 2021: 40 · 2020: 34 · 2019: 28 · 2018: 31 · 2017: 29 · 2016: 34 · 2015: 14
FWCI
15.62
Type
journal article
Language
en
Open access
Locations
  • Cell (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (GM007062)
  • Cancer Prevention and Research Institute of Texas (R1117)
  • U.S. Department of Defense (W81XWH-12-1-0446)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Keywords
AMPK, MAGE-A3, TRIM28, ubiquitination, protein degradation, cancer metabolism, energy homeostasis, autophagy, mTOR signaling, carcinogenesis
MeSH terms
Amino Acid Sequence, Animals, Antigens, Neoplasm, Energy Metabolism, Male, Mice, Inbred BALB C, Mice, Inbred C57BL, Neoplasm Proteins, Neoplasms, Testis, Signal Transduction, Sequence Alignment, Mice, AMP-Activated Protein Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review